0001104659-20-020237.txt : 20200213
0001104659-20-020237.hdr.sgml : 20200213
20200213163203
ACCESSION NUMBER: 0001104659-20-020237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200213
DATE AS OF CHANGE: 20200213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazzano Joseph Walter
CENTRAL INDEX KEY: 0001715291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38114
FILM NUMBER: 20611169
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001644963
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474113275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm208004-2_form4.xml
FORM 4
X0306
4
2020-02-12
0
0001644963
AVENUE THERAPEUTICS, INC.
ATXI
0001715291
Vazzano Joseph Walter
1140 AVENUE OF THE AMERICAS, FLOOR 9
NEW YORK
NY
10036
0
1
0
0
Chief Financial Officer
Restricted Stock Units
0.00
2020-02-12
4
A
0
22727
0.00
A
2025-02-12
Common Stock
22727
50505
D
Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.
/s/ Joseph Vazzano
2020-02-13